Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sara Rodríguez
Observed names:
S. Rodriguez,
Sara Rodriguez
Institutions:
Navarre Institute of Health Research,
Clinica Universidad de Navarra,
Centro de Investigación Médica Aplicada,
Universidad de Navarra
Observed institutions:
Navarre Institute of Health Research,
Centro de Investigación Biomédica en Red,
Clinica Universidad de Navarra,
Centro de Investigación Biomédica en Red de Cáncer,
Centro de Investigación Médica Aplicada,
Universidad de Navarra
show all 6
ORCID:
0000-0001-6509-0447
Observed ORCID:
0000-0001-6509-0447
OpenAlex ID:
A5065358633
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma
2020
·
Ibai Goicoechea
, Noemi Puig
, et al.
·
Blood
·
142
PDF
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma
2020
·
on behalf of the GEM/PETHEMA (Grupo Español de Mieloma/Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study group
, Juan-José Garcés
, et al.
·
Leukemia
·
56
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
2022
·
Rosalinda Termini
, David Žihala
, et al.
·
Clinical Cancer Research
·
55
PDF
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
2023
·
Cirino Botta
, Cristina Perez
, et al.
·
Nature Communications
·
49
PDF
Preneoplastic somatic mutations including MYD88 L265P in lymphoplasmacytic lymphoma
2022
·
Sara Rodriguez
, Jon Celay
, et al.
·
Science Advances
·
49
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
2021
·
Daniel Alameda
, Ibai Goicoechea
, et al.
·
Blood
·
33
PDF
Waldenström’s Macroglobulinemia: An Exploration into the Pathology and Diagnosis of a Complex B-Cell Malignancy
2021
·
Elham Askari
, Sara Rodriguez
, et al.
·
Journal of Blood Medicine
·
18
PDF
Single-Cell Characterization of the Multiple Myeloma (MM) Immune Microenvironment Identifies CD27-Negative T Cells As Potential Source of Tumor-Reactive Lymphocytes
2019
·
Cirino Botta
, Cristina Pérez Ruiz
, et al.
·
Blood
·
10
Discordances between Immunofixation (IFx) and Minimal Residual Disease (MRD) Assessment with Next-Generation Flow (NGF) and Sequencing (NGS) in Patients (Pts) with Multiple Myeloma (MM): Clinical and Pathogenic Significance
2020
·
Sara Rodríguez
, Ibai Goicoechea
, et al.
·
Blood
·
6
Single-Cell Characterization of Multiple Myeloma (MM) Immune Microenvironment Identifies CD27-negative T cells as Potential Tumor-Reactive Lymphocytes
2019
·
Cirino Botta
, Cristina Pérez Ruiz
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
4
Remodeling of the Immune Microenvironment By Oncogenic MYD88 Dictates Immunotherapy Responses across Indolent and Aggressive B-Cell Lymphomas
2023
·
Jon Celay
, Miriam Recalde
, et al.
·
Blood
·
3
Waldenström's Macroglobulinemia (WM) Is Preceded By Clonal Lymphopoiesis Including MYD88 L265P in Progenitor B Cells
2020
·
Sara Rodríguez
, Cirino Botta
, et al.
·
Blood
·
3
Flowct: A Semi-Automated Workflow for Deconvolution of Immunophenotypic Data and Objective Reporting on Large Datasets
2019
·
Cirino Botta
, Catarina Maia
, et al.
·
Blood
·
3
The Pathogenesis of Multiple Myeloma (MM) Is Preceded By Mutated Lymphopoiesis and B Cell Oligoclonality That Persist in Patients with Negative Minimal Residual Disease (MRD)
2019
·
Sara Rodríguez
, Noemi Puig
, et al.
·
Blood
·
2
Longitudinal Immunogenomic Profiling of Tumor and Immune Cells for Minimally-Invasive Monitoring of Smoldering Multiple Myeloma (SMM): The Immunocell Study
2020
·
Rosalinda Termini
, Evangelos Terpos
, et al.
·
Blood
·
1
FlowCT: A semi-automated workflow for deconvolution of immunophenotypic data and objective reporting on large datasets
2019
·
Catarina Maia
, Cirino Botta
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
S121 Single-cell Characterization of the Multiple Myeloma (mm) Immune Microenvironment Identifies Cd27- T Cells as Potential Source of Tumor-reactive Lymphocytes
2019
·
C. Botta
, C. Perez
, et al.
·
HemaSphere
·
1
Supplementary Figure from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
2023
·
Rosalinda Termini
, David Žihala
, et al.
Supplementary Figure from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
2023
·
Rosalinda Termini
, David Žihala
, et al.
PDF
Supplementary Figure from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
2023
·
Rosalinda Termini
, David Žihala
, et al.
PDF
Supplementary Figure from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
2023
·
Rosalinda Termini
, David Žihala
, et al.
PDF
Supplementary Table from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
2023
·
Rosalinda Termini
, David Žihala
, et al.
Supplementary Figure from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
2023
·
Rosalinda Termini
, David Žihala
, et al.
Supplementary Figure from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
2023
·
Rosalinda Termini
, David Žihala
, et al.
PDF
Supplementary Figure from Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
2023
·
Rosalinda Termini
, David Žihala
, et al.
PDF
Show more works
View as search
Works count:
56
Citation count:
436
H-index:
8
I10-index:
8
Year
Topic
Type